Changing aspects of global tuberculosis testing market
The global tuberculosis testing market is driven increased cases of diseases worldwide. Other factors responsible for changing aspects of global tuberculosis testing market are-
• Technological advancements in tuberculosis advancement testing
• Government initiatives for early detection of the diseases and availability of point of care products is boosting the market growth.
However, R&D cost for the development of the new testing procedures for TB will hamper the market growth of global tuberculosis testing.
Market summary:
The market is merged with other strong market players involved in R&D and marketing of the tuberculosis tests. The key strategies adopted are partnerships, mergers and acquisitions to strengthen their market position and expand their global reach.
For instance, Abbott Laboratories joined forces with Alere Inc., to become a market players in point of care testing and stretch out in global market in 2017. In addition to this, there were new product launches and novel technologies to increase their market share.
Regional Analysis:
North America tuberculosis testing market have a significant market share due to the existence of key market players, and established healthcare infrastructure. In addition to this, factors such as recent product launches, strategical collaborations and acquisitions especially in U.S. is growing the North American tuberculosis testing market.
Read more Insights at https://www.precisionbusinessinsights.com/market-reports/tuberculosis-testing-market/
Europe tuberculosis testing market shows a notable growth rates owing to the occurrence of tuberculosis, hi-tech improvements in the diagnostic tests coupled with the growing awareness for early diagnosis and treatment of TB. Asia Pacific tuberculosis testing market is to have lucrative growth opportunity due to the increased disease cases, developing healthcare infrastructure and initiatives taken by the government to increase awareness and funding for early detection of tuberculosis.
Some of the key players in global tuberculosis testing market include-
• Hologic, Inc. (U.S.)
• Thermo Fisher Scientific, Inc. (U.S.)
• Becton, Dickinson and Company (U.S.)
• Abbott Laboratories (U.S.)
• bioMerieux SA (Institut Mérieux) (France)
• Hoffmann-La Roche AG (Switzerland)
• Cepheid (The Danaher Corporation) (U.S.)
• Sanofi S.A. (France)
• QIAGEN (Germany)
• Hain Lifescience GmbH (Germany)
Notable market development:
Rutgers New Jersey Medical School and FIND propelled Xpert MTB/RIF Ultra for TB diagnosis and rifampicin resistance in 2017.
Download free sample report at https://precisionbusinessinsights.com/request-sample?product_id=19561
The global tuberculosis testing market is divided into following categories-
By test type
• Culture Based Tests
• Mantoux Test (TST)
• Interferon Gamma Release Analysis (IGRA)
• Nucleic Acid Testing
• Sear Microscopy
• Serological Tests
By end-users
• Hospitals
• Diagnostic Centers
• Others
By geographical regions
• North America
• Latin America
• Asia Pacific
• The Middle East and Africa
• Europe
Contact us
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com